These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4739142)

  • 1. On therapeutic equivalency and the antisubstitution laws.
    Schiffman DO
    JAMA; 1973 Jan; 223(5):552-3. PubMed ID: 4739142
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug antisubstitution laws.
    Kean EW
    JAMA; 1972 Nov; 222(8):1062. PubMed ID: 4678957
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug antisubstitution laws: reprise.
    JAMA; 1972 Aug; 221(7):711. PubMed ID: 5068273
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Drug antisubstitution laws: further comment.
    Hussey HH
    JAMA; 1975 Apr; 232(4):381. PubMed ID: 1173134
    [No Abstract]   [Full Text] [Related]  

  • 5. Joint statement on antisubstitution laws and regulations.
    JAMA; 1973 Jul; 225(2):142. PubMed ID: 4740275
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug product selection legislation: a comparative analysis.
    Wetherbee H; Sharpe TR
    Am J Pharm Sci Support Public Health; 1978; 150(6):171-6. PubMed ID: 576098
    [No Abstract]   [Full Text] [Related]  

  • 7. Generic drug equivalents: opening Pandora's Rx.
    Regulation; 1979; 3(3):4-5. PubMed ID: 10242344
    [No Abstract]   [Full Text] [Related]  

  • 8. Forces and direction of drug product selection legislation.
    Stewart JE
    Med Mark Media; 1979 Jun; 14(6):34-6, 38-9. PubMed ID: 10242281
    [No Abstract]   [Full Text] [Related]  

  • 9. The substitution issue.
    Archambault GF
    Drug Intell Clin Pharm; 1982 Oct; 16(10):803-4. PubMed ID: 7140519
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Antisubstitution vs. cooperative substitution.
    Jones ME; Helling DK; Widmer RB
    Am Fam Physician; 1976 Jul; 14(1):27. PubMed ID: 937160
    [No Abstract]   [Full Text] [Related]  

  • 11. New York's generic drug substitution law.
    Kamen A
    N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic issues in the antisubstitution controversy.
    Sharpe TR
    Am J Pharm Sci Support Public Health; 1977; 149(2):53-9. PubMed ID: 910879
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug product selection--Part 1: History and legal overview.
    Parker RE; Martinez DR; Covington TR
    Am Pharm; 1991 Jul; NS31(7):72-9. PubMed ID: 1951036
    [No Abstract]   [Full Text] [Related]  

  • 14. Generic substitution laws--physicians' liability.
    Trout ME
    J Leg Med (N Y); 1977 Jul; 5(7):14-6. PubMed ID: 301915
    [No Abstract]   [Full Text] [Related]  

  • 15. Antisubstitution law controversy--a solution?
    Strom BL; Stolley PD; Brown TC
    Ann Intern Med; 1974 Aug; 81(2):254-8. PubMed ID: 4846108
    [No Abstract]   [Full Text] [Related]  

  • 16. Generic equivalence and non-equivalence of drugs.
    Smith RN
    Lancet; 1972 Sep; 2(7776):528-30. PubMed ID: 4115582
    [No Abstract]   [Full Text] [Related]  

  • 17. Generic prescribing and the drug industry.
    Br Med J (Clin Res Ed); 1982 Mar; 284(6320):919. PubMed ID: 6802347
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug product selection in Florida--all it could be?
    Welsh JS
    Am Pharm; 1979 Sep; 19(10):12-3. PubMed ID: 539530
    [No Abstract]   [Full Text] [Related]  

  • 19. Curtailment of prescribing in the National Health Service.
    Lancet; 1984 Nov; 2(8412):1136-7. PubMed ID: 6150189
    [No Abstract]   [Full Text] [Related]  

  • 20. The Ohio Generic Product Selection Law: influence on pharmacy practice.
    Hunter RH
    Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.